Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis (Q38241416)

31 August 2017

0 references

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis (English)

1 reference

31 August 2017

0 references

1 reference

1 reference

4

1 reference

31 August 2017

1

Giovanni Corona

1 reference

31 August 2017

7

Mario Maggi

1 reference

31 August 2017

3

Giulia Rastrelli

1 reference

31 August 2017

6

Edoardo Mannucci

1 reference

31 August 2017

5

Alessandra Sforza

1 reference

31 August 2017

2

Elisa Maseroli

1 reference

PubMed ID

25139126

31 August 2017

language of work or name

English

0 references

publication date

19 August 2014

1 reference

Expert Opinion on Drug Safety

31 August 2017

1 reference

31 August 2017

13

1 reference

31 August 2017

1327-1351

1 reference

31 August 2017

10

1 reference

Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment

31 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Emerging medication for the treatment of male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone supplementation and sexual function: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone supplementation in heart failure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone treatment of men with alcoholic cirrhosis: A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

A trial of testosterone therapy for HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of muscle strength training and testosterone in frail elderly males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

DHEA in elderly women and DHEA or testosterone in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Therapeutic effectiveness of oral testosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of Androgen on Sexual Behavior in Hypogonadal Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

No Effect of Oral Testosterone Treatment on Sexual Dysfunction in Alcoholic Cirrhotic Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Psychosexual behavior in hypopituitary men: a controlled comparison of gonadotropin and testosterone replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone therapy on QT dispersion in men with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

The use of phosphodiesterase 5 inhibitors with concomitant medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Risks and benefits of late onset hypogonadism treatment: an expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

False alarms and pseudo-epidemics: the limitations of observational epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone, cardiovascular disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Testosterone therapy decreases subcutaneous fat and adiponectin in aging men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

Lifespan and testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950653

10.1517/14740338.2014.950653

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25139126